Roundup: Lunit gets new CE mark for AI DBT solution and more briefs
Summary
In a press statement, Lunit disclosed its plan to start rolling out the software product in Europe by the end of March, noting an uptick in interest. According to a press statement, their partnership seeks to verify the educational benefits of medical VR and its implementation in North America. Called Ab-CoV, the online database includes antibody features such as binding affinity and neutralisation profiles, source, and identifying viral proteins and strains. "Ab-CoV is an exhaustive repository of antibodies, not just specific to SARS-CoV-2, but also to other members of the coronavirus family, such as SARS and MERS viruses," Dr Vani Janakirama of the Department of Biotechnology explained. "This repository would aid in comparative studies among different neutralising antibodies across coronaviruses and assess their properties and interaction patterns with epitopes on the native and mutant viral proteins.
Classifications
AskAI Classifications
LabelsLinked Companies
